Assess whether the MRO interview was complete enough to verify (623c28)

SITUATION Program Design and Audit work in a company transitioning to oral fluid now turns on the MRO interview was because a collector who skipped the bluing agent put return-to-duty follow-up testing calendar in play. Medical review officer should say what return-to-duty follow-up testing calendar proves.

DECISION Medical review officer in a company transitioning to oral fluid must choose Accept the result / Reject on custody / Recollect / Hold using return-to-duty follow-up testing calendar after a collector who skipped the bluing agent.

HYPOTHESES TO TEST 1. Authorize Accept the result now; return-to-duty follow-up testing calendar already has the discriminator after a collector who skipped the bluing agent. 2. Keep Reject on custody in force until return-to-duty follow-up testing calendar is completed after a collector who skipped the bluing agent for medical review officer. 3. Treat return-to-duty follow-up testing calendar as Recollect because both readings appear after a collector who skipped the bluing agent. 4. Refuse a Forensic Drug Testing close: medical review officer does not have the decision the MRO interview was turns on in return-to-duty follow-up testing calendar.

ANALYSIS REQUIRED 1. Check MRO notes and cutoffs against the protocol a company transitioning to oral fluid claims to run. 2. Walk chain of custody, collection site, and validity flags in return-to-duty follow-up testing calendar after a collector who skipped the bluing agent. 3. Name the step medical review officer cannot reconstruct from return-to-duty follow-up testing calendar. 4. For this Forensic Drug Testing Program Design and Audit file, read return-to-duty follow-up testing calendar against a collector who skipped the bluing agent and write the one fact that would move the MRO interview was for medical review officer.

RECOMMENDATION Choose Accept the result / Reject on custody / Recollect / Hold on this Forensic Drug Testing / Program Design and Audit packet (return-to-duty follow-up testing calendar after a collector who skipped the bluing agent). Lead with the Forensic Drug Testing option return-to-duty follow-up testing calendar can support after a collector who skipped the bluing agent, then the two facts that force it, then the Monday action for medical review officer in a company transitioning to oral fluid.

COMMAND RETURNS - Bottom-line Forensic Drug Testing option on the MRO interview was, then the evidence in return-to-duty follow-up testing calendar, then the action for medical review officer - Hypothesis scorecard against return-to-duty follow-up testing calendar: supported / rejected / untestable - Program Design and Audit finding in return-to-duty follow-up testing calendar that a second reviewer can re-perform - Missing page in return-to-duty follow-up testing calendar after a collector who skipped the bluing agent, if any